Sparfosic acid trisodium

• CAT Number: I017241
• CAS Number: 70962-66-2
• Molecular Formula: C₆H₇NNa₃O₈P
• Molecular Weight: 321.06
• Purity: ≥95%
• Target: Apoptosis
• IUPAC Name: trisodium;(2S)-2-[[2-[hydroxy(oxido)phosphoryl]acetyl]amino]butanedioate
• InChI: InChI=1S/C6H10NO8P.3Na/c8-4(2-16(13,14)15)7-3(6(11)12)1-5(9)10;;;/h3H,1-2H2,(H,7,8)(H,9,10)(H,11,12)(H2,13,14,15);;;/q;3*+1/p-3/t3-;;;/m0.../s1
• InChIKey: LKLUEGVLTGGBIX-LHWPGRLPSA-K
• SMILES: C([C@@H](C(=O)[O-])NC(=O)CP(=O)(O)[O-])C(=O)[O-].[Na+].[Na+].[Na+]

Sparfosic Acid Trisodium(CAT: I017241) is a potent and specific inhibitor of aspartate transcarbamoylase (ATCase), a key enzyme in pyrimidine biosynthesis. By targeting ATCase, it effectively suppresses the de novo synthesis of nucleotides, making it a valuable tool in oncology research. This inhibition disrupts cancer cell proliferation, providing insights into the metabolic dependencies of tumor cells. Sparfosic Acid Trisodium is widely used in studies exploring the metabolic vulnerabilities of cancer and potential therapeutic interventions. Its high specificity and reliability make Sparfosic Acid Trisodium an essential compound for advancing cancer metabolism research and drug development strategies.